Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:10
  • preuzimanja u poslednjih 30 dana:5
članak: 1 od 1  
Back povratak na rezultate
Vojnosanitetski pregled
2016, vol. 73, br. 11, str. 1016-1021
jezik rada: engleski
vrsta rada: izvorni naučni članak
doi:10.2298/VSP150114138R

Creative Commons License 4.0
Prevalencija metaboličkog sindroma kod bolesnika sa psorijazom u Crnoj Gori
aClinic of Dermatology and Venereology, Clinical Center of Montenegro, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro
bUniverzitet u Beogradu, Medicinski fakultet, Institut za socijalnu medicinu
cUniverzitet u Beogradu, Medicinski fakultet, Institut za epidemiologiju

e-adresa: slavenkaj@gmail.com

Projekat

Kliničko epidemiološka istraživanja poremećaja zdravlja od javnozdravstvenog značaja za stanovništvo Srbije (MPNTR - 175025)

Sažetak

Uvod/Cilj. Sve veći broj epidemioloških studija ukazuje na povezanost psorijaze sa metaboličkim sindromom. Cilj ove studije bio je da se proceni veza između metaboličkog sindroma i njegovih komponenti i psorijaze u uzorku bolesnika sa ovom bolešću iz Crne Gore, kao i da se predvide faktori koji determinišu metabolički sindrom. Metode. Studija slučajeva i kontrola sprovedena je na Klinici za dermatologiju i venerologiju Kliničkog centra Crne Gore, Podgorica, Crna Gora, u periodu januar-decembar, 2012. godine. U grupi obolelih bio je 101 bolesnik sa dijagnozom psorijaze, dok su kontrolnu grupu činili konsekutivni pacijenti iste klinike koji nisu imali psorijazu (126), već neku drugu kožnu bolest. Rezultati. Prevalencija metaboličkog sindroma bila je veća kod bolesnika sa psorijazom u poređenju sa bolesnicima iz kontrolne grupe [48,5% naspram 20,6%; unakrsni odnos (UO) = 2,99]. Bolesnici sa psorijazom bili su statistički značajno češće pušači (UO = 2,16) i manje fizički aktivni (UO = 0,58). Zaključak. Rezultati ove studije pokazuju jaku povezanost između psorijaze i metaboličkog sindroma, nezavisno od težine kliničke slike. Bolesnike sa psorijazom treba podvrgnuti redovnom pregledu na prisustvo metaboličkog sindroma i njegovih komponenti.

Ključne reči

Reference

Albareda, M., Ravella, A., Castelló, M., Saborit, S., Peramiquel, L., Vila, L. (2014) Metabolic syndrome and its components in patients with psoriasis. SpringerPlus, 3(1): 612
Armstrong, A.W., Harskamp, C.T., Dhillon, J.S., Armstrong, E.J. (2014) Psoriasis and smoking: a systematic review and meta-analysis. British journal of dermatology, 170(2): 304-14
Armstrong, A.W., Schupp, C., Wu, J., Bebo, B. (2012) Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003-2011. PLoS ONE, 7(12): e52935
Armstrong, A.W., Harskamp, C.T., Armstrong, E.J. (2013) Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. Journal of the American Academy of Dermatology, 68(4): 654-62
Armstrong, A.W., Harskamp, C.T., Armstrong, E.J. (2013) The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. Journal of hypertension, 31(3): 433-42; discussion 442-3
Armstrong, A.W., Harskamp, C.T., Armstrong, E.J. (2013) Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA dermatology, 149(1): 84-91
Baeta, I.G.R., Bittencourt, F.V., Gontijo, B., Goulart, E.M.A. (2014) Comorbidities and cardiovascular risk factors in patients with psoriasis. Anais Brasileiros de Dermatologia, 89(5): 735-744
Balato, N., Megna, M., Palmisano, F., Patruno, C., Napolitano, M., Scalvenzi, M., Ayala, F. (2015) Psoriasis and sport: a new ally?. Journal of the European Academy of Dermatology and Venereology, 29(3): 515-20
Cohen, A., Gilutz, H., Henkin, Y., Zahger, D., Shapiro, J., Bonneh, D., Vardy, D. (2007) Psoriasis and the Metabolic Syndrome. Acta Dermato-Venereologica, 87(6): 506-509
Danielsen, K., Wilsgaard, T., Olsen, A.O., Eggen, A.E., Olsen, K., Cassano, P.A., Furberg, A. (2015) Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. British journal of dermatology, 172(2): 419-27
Frankel, H.C., Han, J., Li, T., Qureshi, A.A. (2012) The Association Between Physical Activity and the Risk of Incident Psoriasis. Archives of Dermatology, 148(8): 918-24
Fredriksson, T., Pettersson, U. (1978) Severe psoriasis: oral therapy with a new retinoid. Dermatologica, 157(4): 238-44
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., Girolomoni, G. (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. British journal of dermatology, 157(1): 68-73
Gisondi, P., Ferrazzi, A., Girolomoni, G. (2010) Metabolic Comorbidities and Psoriasis. Acta Dermatovenerol Croat, 18(4); 297-304
Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A. (2005) Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17): 2735-2752
Herron, M.D., Hinckley, M., Hoffman, M.S., Papenfuss, J., Hansen, C.B., Callis, K.P., Krueger, G.G. (2005) Impact of obesity and smoking on psoriasis presentation and management. Archives of dermatology, 141(12): 1527-34
Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., Taskinen, M.R., Groop, L., i dr. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4): 683-9
Jankovic, S., Raznatovic, M., Marinkovic, J., Jankovic, J., Maksimovic, N. (2009) Risk factors for psoriasis: A case-control study. Journal of dermatology, 36(6): 328-34
Jankovic, S.M., Raznatovic, M., Marinkovic, J.M., Jankovic, J., Kocev, N.I., Tomic-Spiric, V., Vasiljevic, N.D. (2011) Health-Related Quality of Life in Patients with Psoriasis. Journal of Cutaneous Medicine and Surgery, vol. 15, br. 1, str. 29-36
Kim, G., Park, H., Kim, H., Kim, S., Ko, H., Kim, B., Kim, M., Sim, E. (2012) Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis. Annals of dermatology, 24(1): 11-5
Klein, B. E.K., Klein, R., Lee, K. E. (2002) Components of the Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes in Beaver Dam. Diabetes Care, 25(10): 1790-1794
Lakshmi, S., Nath, A.K., Udayashankar, C. (2014) Metabolic syndrome in patients with psoriasis: A comparative study. Indian dermatology online journal, 5(2): 132-7
Langan, S.M., Seminara, N.M., Shin, D.B., Troxel, A.B., Kimmel, S.E., Mehta, N.N., Margolis, D.J., Gelfand, J.M. (2012) Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom. Journal of Investigative Dermatology, 132(3): 556-562
Love, T.J., Qureshi, A.A., Karlson, E.W., Gelfand, J.M., Choi, H.K. (2011) Prevalence of the Metabolic Syndrome in Psoriasis. Archives of Dermatology, 147(4): 419
Mallbris, L., Ritchlin, C.T., Ståhle, M. (2006) Metabolic disorders in patients with psoriasis and psoriatic arthritis. Current rheumatology reports, 8(5): 355-63
Mebazaa, A., El, A.M., Zidi, W., Zayani, Y., Cheikh, R.R., El, O.S., Kanoun, F., Mokni, M., Osman, A., Feki, M., Slimane, H., Mebazaa, A., Kaabachi, N. (2011) Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. Journal of the European Academy of Dermatology and Venereology, 25(6): 705-9
Menter, M.A., Griffiths, C.E. (2015) Psoriasis: the future. Dermatol Clin, 33(1); 161-6
Miller, I.M., Ellervik, C., Zarchi, K., Ibler, K.S., Vinding, G.R., Knudsen, K.M., Jemec, G.B. (2015) The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study. Journal of the European Academy of Dermatology and Venereology, 29(3): 490-7
Naldi, L., Peli, L., Parazzini, F., Carrel, C.F. (2001) Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: Results of a case-control study. Journal of the American Academy of Dermatology, 44(3): 433-8
Naldi, L., Addis, A., Chimenti, S., Giannetti, A., Picardo, M., Tomino, C., Maccarone, M., Chatenoud, L., Bertuccio, P., Caggese, E., Cuscito, R. (2008) Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology (Basel, Switzerland), 217(4): 365-73
Naldi, L., Chatenoud, L., Linder, D., Belloni, F.A., Peserico, A., Virgili, A.R., Bruni, P.L., Ingordo, V., Lo, S.G., Solaroli, C., Schena, D., Barba, A., di Landro, A. (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. Journal of investigative dermatology, 125(1): 61-7
Neimann, A.L., Shin, D.B., Wang, X., Margolis, D.J., Troxel, A.B., Gelfand, J.M. (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. Journal of the American Academy of Dermatology, 55(5): 829-35
Nisa, N., Qazi, M. (2010) Prevalence of metabolic syndrome in patients with psoriasis. Indian Journal of Dermatology, Venereology, and Leprology, 76(6): 662
Prizment, A.E., Alonso, A., Folsom, A.R., Ahmed, R.L., Virnig, B.A., Warshaw, E.M., Anderson, K.E. (2011) Association between psoriasis and incident cancer: the Iowa’s Women’s Health Study. Cancer Causes & Control, 22(7): 1003-1010
Qureshi, A.A., Choi, H.K., Setty, A.R., Curhan, G.C. (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Archives of dermatology, 145(4): 379-82
Radtke, M.A., Augustin, M. (2008) Economic considerations in psoriasis management. Clinics in Dermatology, 26(5): 424-431
Raychaudhuri, S.P., Gross, J. (2000) Psoriasis risk factors: role of lifestyle practices. Cutis, 66(5): 348-52
Ryan, C., Kirby, B. (2015) Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatologic clinics, 33(1): 41-55
Sampogna, F., Chren, M.M., Melchi, C.F., Pasquini, P., Tabolli, S., Abeni, D. (2006) Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. British journal of dermatology, 154(2): 325-31
Shin, J., Lee, J., Lim, S., Ha, H., Kwon, H., Park, Y., Lee, W., Kang, M., Yim, H., Yoon, K., Son, H. (2013) Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. Journal of diabetes investigation, 4(4): 334-43
Sommer, D.M., Jenisch, S., Suchan, M., Christophers, E., Weichenthal, M. (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Archives of dermatological research, 298(7): 321-8
Takahashi, H., Iizuka, H. (2012) Psoriasis and metabolic syndrome. Journal of dermatology, 39(3): 212-8
Timotijević, Z.S., Janković, S., Trajković, G., Majcan, P., Perišić, S., Dostanić, N., Hudomal, S.J., Janković, J. (2013) Identification of psoriatic patients at risk of high quality of life impairment. Journal of Dermatology, 40(10): 797-804
Wilson, P. W.F. (2005) Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. Circulation, 112(20): 3066-3072
Wilson, P.B., Bohjanen, K.A., Ingraham, S.J., Leon, A.S. (2012) Psoriasis and physical activity: a review. Journal of the European Academy of Dermatology and Venereology, 26(11): 1345-1353
Wolk, K., Mallbris, L., Larsson, P., Rosenblad, A., Vingård, E., Ståhle, M. (2009) Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta dermato-venereologica, 89(5): 492-7
World Health Organisation Body mass index. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi
Zindancı, I., Albayrak, O., Kavala, M., Kocaturk, E., Can, B., Sudogan, S., Koç, M. (2012) Prevalence of Metabolic Syndrome in Patients with Psoriasis. Scientific World Journal, 2012: 1-5